Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
For full access to this article login to GEN Select now.
Viral Clearance for Single Use and Steel
Don’t be satisfied with existing techniques for detecting and removing viral contaminants from recombinant bioproducts. Regulatory bodies aren’t.
- Viral clearance and quality control remain key challenges for biomanufacturers involved in both single-use and/or steel applications. New approaches and the latest thinking on ways to deal with viral clearance were topics of discussion at the recent Sartorius Stedim Biotech “European Upstream and Downstream Technology Forum,” which was held ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.